Table 4.

Clinical response of 2% ganciclovir eye drop compared with baseline 1 week–6 months

	Baseline	1 week	4 weeks	2 months	3 months	4 months	5 months	6 months
	Median (min–max)	Median (min–max)	Median (min–max)	Median (min–max)	Median (min–max)	Median (min–max)	Median (min–max)	Median (min–max)
Visual acuity	0.2 (0–1.4)	0.3 (0–1.4)	0.5 (0–1.1)	0.2 (0–1.3)	0.4 (0–1.3)	0.2 (0–1.1)	0.2 (0–1.1)	0.1 (0–1.1)
		p = 0.031	p = 0.095	p = 0.078	p = 0.065	p= 0.065	p= 0.020	p= 0.011
Cell	0.5 (0–4)	0 (0–3)	0 (0–1)	0 (0–1)	0 (0–0.5)	0 (0–2)	0 (0–1)	0 (0–1)
		p = 0.058	p = 0.034	p = 0.020	p = 0.007	p= 0.008	p= 0.034	p= 0.007
IOP	28 (14–44)	13 (12–20)	15 (8–18)	14 (8–16)	11 (8–24)	14 (8–16)	14 (9–29)	14 (7–18)
		p = 0.013	p = 0.012	p = 0.006	p = 0.11	p= 0.005	p= 0.012	p= 0.003
Antiglaucoma drug	3 (0–6)	2 (0–5)	2 (0–4)	2 (0–4)	1 (0–3)	1 (0–4)	1 (0–4)	1 (0–3)
		p = 0.024	p = 0.010	p = 0.011	p = 0.007	p= 0.011	p= 0.011	p= 0.007
Steroid	4 (2–16)	4 (0–16)	2 (0–8)	2 (0–4)	2 (0–4)	2 (0–8)	2 (0–4)	1 (0–4)
		p = 0.176	p = 0.017	p = 0.018	p = 0.11	p= 0.005	p= 0.007	p= 0.005
KPs present 10 (90.9%)		4 (36.36%)	0	0	0	0	1 (9.09%)	0
		p = 0.031	NA	NA	NA	NA	p= 0.004	NA

Wilcoxon signed-rank test.

McNemar test.

Significant (p<0.05).

IOP, intraocular pressure; KPs, keratic precipitates.